Effects of a phorbol ester and cyclosporin A on hippocampal synaptic plasticity in streptozotocin-induced-diabetic rats: reduced sensitivity to phorbol esters

Neurosci Lett. 2003 Mar 13;339(1):45-8. doi: 10.1016/s0304-3940(02)01451-9.

Abstract

In streptozotocin-induced diabetic (STZ-diabetic) rats, an animal model of diabetes mellitus, a reduced expression of long-term potentiation (LTP) and enhanced long-term depression (LTD) are observed. This study examined the role of protein kinase C (PKC) and protein phosphatase 2B in hippocampal synaptic transmission in STZ-diabetic rats. The phorbol ester 4beta-phorbol-12,13-dibutyrate (PDB) induced a concentration-dependent potentiation of synaptic responses in area CA1 that could partially be inhibited by the PKC inhibitor chelerythrine. In slices from STZ-diabetic rats the effectivity of PDB to increase synaptic transmission was reduced compared to slices from control animals. In STZ-diabetic rats the protein phosphatase 2B (PP2B) inhibitor cyclosporin A inhibited LTD induction, but did not affect the induction of LTP. In conclusion, these data show a reduced response to PDB in STZ-diabetic rats, and indicate that the lack of LTP induction in these animals is not due to increased PP2B activity.

MeSH terms

  • Alkaloids
  • Animals
  • Benzophenanthridines
  • Calcineurin / metabolism
  • Calcineurin Inhibitors
  • Cyclosporine / pharmacology*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / physiopathology*
  • Enzyme Inhibitors / pharmacology
  • Hippocampus / drug effects*
  • Hippocampus / enzymology
  • Hippocampus / physiopathology
  • In Vitro Techniques
  • Long-Term Potentiation / drug effects
  • Male
  • Phenanthridines / pharmacology
  • Phorbol 12,13-Dibutyrate / pharmacology*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Rats
  • Rats, Wistar
  • Synaptic Transmission / drug effects*

Substances

  • Alkaloids
  • Benzophenanthridines
  • Calcineurin Inhibitors
  • Enzyme Inhibitors
  • Phenanthridines
  • Phorbol 12,13-Dibutyrate
  • Cyclosporine
  • chelerythrine
  • Protein Kinase C
  • Calcineurin